Yu G D, Lian J S, Ye C Y, Ding F, Lu Y F, Hao S R, Yu J, Yang Y D
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Diseases, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Department of Infectious Diseases, Affiliated Hospital of Shaoxing University of Arts and Sciences, Shaoxing 312000, China.
Zhonghua Gan Zang Bing Za Zhi. 2022 May 20;30(5):520-526. doi: 10.3760/cma.j.cn501113-20220404-00164.
To analyze whether there are differences and related influencing factors in liver injury associated with different strains of 2019-nCoV/SARS-CoV-2 infection. Data of epidemiology, clinical symptoms, laboratory tests, and treatment outcomes of patients with COVID-19 infection confirmed with Alpha and Delta virus strain in Zhejiang Province were retrospectively collected. Statistical analysis was performed using independent samples t-test or Mann-Whitney U test, test or Fisher's exact test, and logistic regression analysis. A total of 788 and 381 cases with Alpha and Delta virus strain were included. Vaccination ratio was 0% in Alpha and 85.30% in Delta group (<0.001), The proportion of patients with fever (80.71% . 40.94%, <0.001) was significantly higher in Alpha than Delta strain group. The proportion of critical ill patients was significantly higher in Delta group (9.90% . 1.57%, respectively, <0.001). The virus negative conversion time was significantly longer in Delta than Alpha group (22 d 11 d, <0.001), but the incidence of liver injury was significantly higher in Alpha than Delta group (20.05% . 13.91%, =0.011). Univariate analysis showed that Alpha virus strain infection, male sex, body mass index, chronic liver disease, fever, diarrhea, shortness of breath, severe/critical illness, elevated creatine kinase (CK), elevated international normalized ratio (INR) and an elevated neutrophil/lymphocyte ratio was significantly associated with an increased risk of liver injury occurrence, and in patients with pharyngeal pain the risk of liver injury occurrence was significantly reduced. Multivariate analysis showed that shortness of breath [, 2.667 (: 1.389-5.122); =0.003], increased CK [, 2.544 (: 1.414-4.576); =0.002] and increased INR [OR, 1.721] (: 1.074-2.758); =0.024] was significantly associated with an increased risk of liver injury occurrence, and in patients with pharyngeal pain the risk of liver injury occurrence was significantly reduced [, 0.424 (: 0.254-0.709); =0.001]. Although the virulence of the Delta is stronger than Alpha strain, most patients infected with Delta strain vaccinated against COVID-19 in Zhejiang province had milder clinical symptoms and a lower incidence and degree of liver injury. Notably, the infection risk even remains after vaccination; however, symptoms and the incidence of severe and critical illness can be significantly reduced.
分析2019-nCoV/SARS-CoV-2不同毒株感染所致肝损伤是否存在差异及相关影响因素。回顾性收集浙江省确诊感染阿尔法毒株和德尔塔毒株的新型冠状病毒肺炎患者的流行病学、临床症状、实验室检查及治疗结局数据。采用独立样本t检验或曼-惠特尼U检验、检验或费舍尔精确检验以及逻辑回归分析进行统计分析。共纳入788例阿尔法毒株感染病例和381例德尔塔毒株感染病例。阿尔法组疫苗接种率为0%,德尔塔组为85.30%(<0.001),阿尔法毒株组发热患者比例(80.71%对40.94%,<0.001)显著高于德尔塔毒株组。德尔塔组危重症患者比例显著更高(分别为9.90%对1.57%,<0.001)。德尔塔组病毒转阴时间显著长于阿尔法组(22天对11天,<0.001),但阿尔法毒株组肝损伤发生率显著高于德尔塔组(20.05%对13.91%,=0.011)。单因素分析显示,阿尔法毒株感染、男性、体重指数、慢性肝病、发热、腹泻、气短、重症/危重症、肌酸激酶(CK)升高、国际标准化比值(INR)升高及中性粒细胞/淋巴细胞比值升高与肝损伤发生风险增加显著相关,而咽痛患者肝损伤发生风险显著降低。多因素分析显示,气短[, 2.667(95%置信区间:1.389 - 5.122);=0.003]、CK升高[, 2.544(95%置信区间:1.414 - 4.576);=0.002]及INR升高[比值比,1.721(95%置信区间:1.074 - 2.758);=0.024]与肝损伤发生风险增加显著相关,而咽痛患者肝损伤发生风险显著降低[, 0.424(95%置信区间:0.254 - 0.709);=0.001]。虽然德尔塔毒株的毒力强于阿尔法毒株,但浙江省大多数感染德尔塔毒株且接种过新冠疫苗的患者临床症状较轻,肝损伤发生率及程度较低。值得注意的是,接种疫苗后仍存在感染风险;然而,症状以及重症和危重症的发生率可显著降低。